Structure Therapeutics
GPCR
GPCR
155 hedge funds and large institutions have $1.58B invested in Structure Therapeutics in 2025 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
10% less funds holding
Funds holding: 172 → 155 (-17)
41% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 37
Holders
155
Holding in Top 10
3
Calls
$30.2M
Puts
$19.7M
Top Buyers
| 1 | +$144M | |
| 2 | +$40.1M | |
| 3 | +$28.8M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.9M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$10.4M |
Top Sellers
| 1 | -$33.6M | |
| 2 | -$33.2M | |
| 3 | -$26.7M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$25.7M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$24.9M |
